Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Anti-CD22, Humanized Antibody (In2)

Biosimilar to Inotuzumab Ozogamicin, monoclonal antibody that targets CD22
Catalog #: A2179

Product Details

Cat # +Size A2179-100
Size 100 μg
Antibody Target CD22
Alternate Name SIGLEC2, SIGLEC-2, T-cell surface antigen Leu-14, BL-CAM, Sialic acid-binding Ig-like lectin 2
Host Recombinant
Antibody Type Monoclonal
Isotype IgG4, kappa
Immunogen Human CD22
Accession # DB05889
Gene ID 933
Appearance Colorless liquid
Formulation In PBS, pH 7.5
Purification Protein A purified
Species Reactivity Human
Handling The antibody solution should be gently mixed before use.
Storage Conditions -80°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


The research-grade biosimilar is a recombinant antibody to CD22. CD22 mediates interactions between B cells and may be involved in the localization of B cells in lymphoid tissues. CD22 plays a role in positive regulation of the immune response through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains to block signal transduction through the dephosphorylation of signaling molecules.

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.